Efficacy and safety of immune checkpoint inhibitors in Proficient Mismatch Repair (pMMR)/ Non-Microsatellite Instability-High (non-MSI-H) metastatic colorectal cancer: a study based on 39 cohorts incorporating 1723 patients.

Wu, Qing; Wang, Ziming; Luo, Yang; Xie, Xianhe

Wu, Qing; Wang, Ziming; Luo, Yang; Xie, Xianhe.

Afiliação

Wu Q; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Wang Z; Department of Oncology, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
Luo Y; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Xie X; Department of Oncology, Molecular Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.

BMC Immunol ; 24(1): 27, 2023 09 01.

Article em En | MEDLINE | ID: mdl-37658314

Assuntos

Neoplasias do Colo; Inibidores de Checkpoint Imunológico; Humanos; Inibidores de Checkpoint Imunológico/efeitos adversos; Reparo de Erro de Pareamento de DNA/genética; Terapia Combinada

Palavras-chave

Colorectal cancer; Efficacy; Immune checkpoint inhibitors; Non-MSI-H; Safety; pMMR

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Immunol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google